中國三江化工(02198.HK)年產100萬噸環氧乙烷/乙二醇項目投產
中國三江化工(02198.HK)公布,集團年產100萬噸第六期環氧乙烷/乙二醇項目及配套工程全面實現高標準中交。項目主要建設內容為新建125萬噸/年輕烴利用裝置、100萬噸/年環氧乙烷/乙二醇裝置、25萬噸/年粗芳烴加氫裝置、8萬噸/年丁二烯抽提裝置、3萬噸空分裝置及配套總變、儲運、火炬等公用工程及輔助設施。項目採用多原料配比進料工藝,有效應對單一原料價格風險,提高裝置的盈利能力。
公司指出,項目投產後,解決了集團乙烯及丙烯產業鏈的原料自給自足,進一步完善集團產業鏈佈局,提升整體抗風險能力,為構建循環經濟產業園更上一個台階。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.